Skip to main content

13-11-2019 | Rheumatoid arthritis | Video | Article

Researcher comment: The NORD-STAR trial

Merete Hetland discusses the NORD-STAR trial findings comparing remission rates after active conventional versus biologic treatment in patients with early rheumatoid arthritis (3:52).  

Receive weekly updates on the rheumatology news that matters to you


Back to the ACR/ARP 2019 conference hub

Related topics

How is psoriatic arthritis managed in resource-limited settings?

Rheumatologists from around the world discuss the challenges, guidelines, and research priorities.

Image Credits